The Food and Drug Administration (FDA) approved the first generic versions of Vyvanse, a drug used to treat attention deficit/hyperactivity disorder (ADHD), a decision that comes amid a nationwide ...

The US Food and Drug Administration (FDA) has accepted for priority review Otsuka Pharmaceutical’s new drug application (NDA) submitted for centanafadine, an investigational, once-daily ...

Add Yahoo as a preferred source to see more of our stories on Google. Close-up of a person holding a pill bottle pouring medication in a stock photo. (Trevor Williams/Getty Images) A commonly used ...

In a bid to expand its reach in the attention-deficit/hyperactivity disorder (ADHD) market, Collegium Pharmaceutical has struck a deal to ...

A large multicenter clinical trial led by King's College London with 150 children and adolescents has shown that a device cleared by the US FDA to treat ADHD is not effective in reducing symptoms.

Add Yahoo as a preferred source to see more of our stories on Google. A commonly prescribed medication for attention-deficit hyperactivity disorder (ADHD) has been recalled nationwide after failing to ...

KANSAS CITY, Kan., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (CING) (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform ...

Understood reports concerns about ADHD medication overprescription, noting 7 million U.S. kids have been diagnosed, yet many ...

ADHD drug shortage tied to supply chain failures as Yale study links U.S. stimulant import declines to production cutbacks and concentrated sources.

A large multicenter clinical trial led by King's College London with 150 children and adolescents has shown that a device cleared by the US FDA to treat ADHD is not effective in reducing symptoms. The ...

Kenvue, the American company that makes Tylenol, says the U.S. Food and Drug Administration should not make proposed changes to the product’s safety label to reflect research about a possible ...